In this double-blind , randomized , placebo-controlled , multicenter study , patients with New York Heart Association Class II to III chronic heart failure , left ventricular ejection fraction @ % , and estimated glomerular filtration rate ( GFR ) @ to @ mL/min per @ m ( @ ) received intravenous serelaxin @ g/kg per day or placebo for @ hours .